Robert Holmlin

Robert Holmlin

Director/Board Member at
Xagenic, Inc.

Net worth: 1 208 $ as of 31/08/2026

58 year
Health Technology
Consumer Services
Finance

Profile

Robert Erik Holmlin was the founder of GeneOhm Sciences, Inc., founded in 2001, where the title held was Vice President-Business Development from 2001 to 2012.
Current jobs include Director at Xagenic, Inc. since 2012 and Director at Innovatus Life Sciences Acquisition Corp.
since 2021.
Former jobs include President, CEO, CFO & Director at Bionano Genomics, Inc. from 2024 to 2026; President & Chief Executive Officer at GenVault Corp.
from 2010 to 2011; Independent Director at Nanosphere, Inc.; Director at Applied Proteomics, Inc.; Entrepreneur-in-Residence at Domain Associates LLC; Vice President-Marketing & Development at Becton, Dickinson & Co. from 2006 to 2008; and Chief Commercial Officer at Exiqon A from 2008 to 2009.
Education includes an MBA from The Trustees of Columbia University in The City of New York, a doctorate from California Institute of Technology, an undergraduate degree from Occidental College, and an MBA from the University of California, Berkeley.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/03/2026 990 ( 0.01% ) 1 208 $ 31/08/2026

Robert Holmlin active positions

CompaniesPositionStart
Director/Board Member 11/09/2012
Director/Board Member 01/03/2021

Former positions of Robert Holmlin

CompaniesPositionEnd
BIONANO GENOMICS, INC. Chief Executive Officer 05/05/2026
Chief Executive Officer 01/02/2011
EXIQON A/S Corporate Officer/Principal 01/11/2009
BECTON, DICKINSON AND COMPANY Sales & Marketing 01/07/2008
Corporate Officer/Principal -
See the detail of Robert Holmlin's experience

Training of Robert Holmlin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

69

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Technology Services

Finance

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

  1. Stock Market
  2. Insiders
  3. Robert Holmlin
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!